SDZ-62-434
SDZ-62-434, a platelet-activating factor inhibitor with antitumor activity, inhibits bombesin- and platelet-derived growth factor-induced DNA synthesis in quiescent Swiss 3T3 cells, making it a potential candidate for studying leukemia, human xenograft colorectal cancer, and lung cancer.
Product Specifications
CAS Number
115621-95-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
416.39
Molecular Formula
C23H27Cl2N3
Notes
Research use only, not for human use.
Receptor
Platelet aggregation
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog